» Articles » PMID: 39407877

How Long Is Long COVID? Evaluation of Long-Term Health Status in Individuals Discharged from a Specialist Community Long COVID Service

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Oct 16
PMID 39407877
Authors
Affiliations
Soon will be listed here.
Abstract

Post COVID-19 syndrome or long COVID (LC) is a novel fluctuating condition with a protracted course in some patients. Specialist LC services have been operational in the UK since 2020 and deal with a high caseload of patients. To evaluate long-term outcomes in patients discharged from a community-based LC specialist service. A service evaluation study that included patients who were well engaged in the services [completed the standard Patient Reported Outcome Measures (PROMs) and received intervention from clinician(s)] and had been discharged for at least 3 months from the service. They consented to the study and completed standard PROMs: COVID-19 Yorkshire Rehabilitation Scale (C19-YRS), EQ-5D-5L and National Institute for Health and Care Excellence (NICE) criteria for myalgia encephalomyelitis/chronic fatigue syndrome (ME/CFS). Out of 460 patients contacted, 112 (average of 37.6 months since infection and 9.8 months post-discharge) completed the PROMs. Of these, 90.2% patients continued to experience LC symptoms and disability and had not returned to their pre-COVID-19 health status. The average EQ-5D-5L index score was 0.53 (SD 0.29), highlighting a significant disability and that LC had become a long-term condition (LTC) in the majority of patients who responded to the survey. Of these patients, 43% met the criteria for suspected ME/CFS. A proportion of LC patients develop persistent long COVID (PLC) consistent with a LTC and had a significant overlap with ME/CFS.

Citing Articles

A Personalised Pacing and Active Rest Rehabilitation Programme for Post-Exertional Symptom Exacerbation and Health Status in Long COVID (PACELOC): A Prospective Cohort Study.

Godfrey B, Shardha J, Witton S, Bodey R, Tarrant R, Greenwood D J Clin Med. 2025; 14(1.

PMID: 39797180 PMC: 11722468. DOI: 10.3390/jcm14010097.


The Role of the Six-Minute Walk Test in the Functional Evaluation of the Efficacy of Rehabilitation Programs After COVID-19.

Tache-Codreanu D, Bobocea L, David I, Burcea C, Sporea C Life (Basel). 2024; 14(11).

PMID: 39598312 PMC: 11595584. DOI: 10.3390/life14111514.

References
1.
Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

2.
Tokumasu K, Honda H, Sunada N, Sakurada Y, Matsuda Y, Yamamoto K . Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina (Kaunas). 2022; 58(7). PMC: 9325226. DOI: 10.3390/medicina58070850. View

3.
Sivan M, Greenhalgh T, Darbyshire J, Mir G, OConnor R, Dawes H . LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK. BMJ Open. 2022; 12(5):e063505. PMC: 9114312. DOI: 10.1136/bmjopen-2022-063505. View

4.
Smith A, Greenwood D, Horton M, Osborne T, Goodwin M, Lawrence R . Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study. BMJ Open Respir Res. 2024; 11(1). PMC: 11086182. DOI: 10.1136/bmjresp-2023-002271. View

5.
Janssen M, Pickard A, Shaw J . General population normative data for the EQ-5D-3L in the five largest European economies. Eur J Health Econ. 2021; 22(9):1467-1475. PMC: 8558182. DOI: 10.1007/s10198-021-01326-9. View